Global Cardiac Pacemaker Market on the Rise with Expected Growth to US$ 6.8 Billion by 2032 [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering. The cardiac pacemaker industry is poised for significant growth, as reported in recent market analysis. Factors propelling this advancement include an uptick in cardiovascular disease (CVD) prevalence, a growing aging demographic prone to heart conditions, and heightened awareness of treatment options. Moreover, the accessibility to health insurance is alleviating the financial burden for patients in need of cardiac pacemakers, further energizing market expansion. The innovation spearheaded by leading players is delivering pacemakers with enhanced battery longevity and remote patient monitoring capabilities. Industry players are continually seeking to improve the patient experience by introducing smaller, less invasive devices, and employing biocompatible materials to decrease risks associated with the implantation process. Segmentation of the Market The comprehensive analysis categorizes t
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Declares 402nd Consecutive Quarterly DividendPR Newswire
- U.S. Liver Cancer Diagnostics Market Analysis Report 2024-2030, by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), End-use and Region [Yahoo! Finance]Yahoo! Finance
- The FDA lost a whistleblower complaint about unsanitary conditions at an infant formula plant for a year, auditors revealed [Fortune]Fortune
- FDA took months to react to complaint about Abbott infant formula factory, audit finds [Yahoo! Finance Canada]Yahoo! Finance Canada
- FDA took months to react to complaint about Abbott infant formula factory, audit finds [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 5/30/24 - Form SD
- 5/14/24 - Form 4
- 5/10/24 - Form 144
- ABT's page on the SEC website